Paper8977944
Continuous infusion of methylene blue for septic shock.
Brown G and 2 others. Postgrad Med J, 1996. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Continuous infusion of methylene blue for septic shock. Papers, record 8977944. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8977944
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antidotes | Major topic |
| Enterococcus faecium | Major topic |
| Gram-Positive Bacterial Infections | Major topic |
| Methylene Blue | Major topic |
| Shock, Septic | Major topic |
| Humans | |
| Infusions, Intravenous | |
| Male | |
| Middle Aged |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1810151 | Anti-tumoral and anti-inflammatory effects of biological stains. | Agents Actions | 1991 | https://conductscience.org/library/papers/1810151 | PubMed |
| 2 | 1527264 | Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. | Intensive Care Med | 1992 | https://conductscience.org/library/papers/1527264 | PubMed |
| 3 | 8093254 | Methylene blue inhibits the antithrombotic effect of nitroglycerin. | J Am Coll Cardiol | 1993 | https://conductscience.org/library/papers/8093254 | PubMed |
| 4 | 7519669 | Possible role of nitric oxide in catecholamine secretion by chromaffin cells in the presence and absence of cultured endothelial cells. | J Neurochem | 1994 | https://conductscience.org/library/papers/7519669 | PubMed |
| 5 | 7956289 | NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. | Crit Care Med | 1994 | https://conductscience.org/library/papers/7956289 | PubMed |
| 6 | 973698 | Dyed but not dead--methylene blue overdose. | Anesthesiology | 1976 | https://conductscience.org/library/papers/973698 | PubMed |
| 7 | 7634806 | Methylene blue increases myocardial function in septic shock. | Crit Care Med | 1995 | https://conductscience.org/library/papers/7634806 | PubMed |
| 8 | 6492250 | Methylene blue: effects and disposition in sheep. | J Vet Pharmacol Ther | 1984 | https://conductscience.org/library/papers/6492250 | PubMed |
| 9 | 3248097 | Methylene blue inhibits the arachidonic acid metabolism in human blood platelets. | Biomed Biochim Acta | 1988 | https://conductscience.org/library/papers/3248097 | PubMed |
| 10 | 2781510 | Methylene blue for neutralization of heparin. | Thromb Res | 1989 | https://conductscience.org/library/papers/2781510 | PubMed |
| 11 | 2244897 | Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. | Biochem Biophys Res Commun | 1990 | https://conductscience.org/library/papers/2244897 | PubMed |
| 12 | 7532559 | Methylene blue administration in septic shock: a clinical trial. | Crit Care Med | 1995 | https://conductscience.org/library/papers/7532559 | PubMed |
| 13 | 6112057 | Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. | Can J Physiol Pharmacol | 1981 | https://conductscience.org/library/papers/6112057 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41477182 | The Effect of Methylene Blue on Sublingual Microcirculation in Patients with Septic Shock: A Randomized Controlled Trial. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/41477182 | PubMed |
| 39780053 | Comparative study between high and low dose methylene blue infusion in septic cancer patients: a randomized, blinded, controlled study. | BMC Anesthesiol | 2025 | https://conductscience.org/library/papers/39780053 | PubMed |
| 37967040 | Anticholinergic Toxidrome as a Possible Explanation for Methylene Blue Toxicity. | Am J Case Rep | 2023 | https://conductscience.org/library/papers/37967040 | PubMed |
| 36505110 | Methylene Blue in Refractory Shock. | Cureus | 2022 | https://conductscience.org/library/papers/36505110 | PubMed |
| 36237547 | Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36237547 | PubMed |
| 32828741 | Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial. | Eur J Pharmacol | 2020 | https://conductscience.org/library/papers/32828741 | PubMed |
| 32705530 | Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review. | Adv Ther | 2020 | https://conductscience.org/library/papers/32705530 | PubMed |
| 32435102 | Extended Continuous Infusion of Methylene Blue for Refractory Septic Shock. | Indian J Crit Care Med | 2020 | https://conductscience.org/library/papers/32435102 | PubMed |
| 23762740 | Use of methylene blue for treatment of severe sepsis in an immunosuppressed patient after liver transplantation. | Case Rep Transplant | 2013 | https://conductscience.org/library/papers/23762740 | PubMed |
| 23580172 | Methylene blue for distributive shock: a potential new use of an old antidote. | J Med Toxicol | 2013 | https://conductscience.org/library/papers/23580172 | PubMed |
| 16134766 | The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock. | Korean J Intern Med | 2005 | https://conductscience.org/library/papers/16134766 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8977944
GET https://conductscience.org/api/papers/v1/8977944/authors